Myasthenia gravis with thymoma

作者
Robert E. Lovelace,David S. Younger
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:48 (suppl_5) 被引量:30
标识
DOI:10.1212/wnl.48.suppl_5.76s
摘要

Progress in the pathogenesis, diagnosis, and treatment of thymomatous myasthenia gravis (MG) has been made in the past several decades. These advances have occurred along diverse lines of immunology, molecular genetics, and tumor cytopathology. The most widely used classification for thymoma closely correlates with tumor biology, prognosis, and the likelihood of association with MG. There is a sensitive immunoassay for the detection of striational autoantibodies, which are closely related to the presence of thymoma, although their precise origin is still debated. Chest computed tomography (CT) can delineate a thymoma with extraordinary accuracy and sensitivity. The goal of treatment is complete removal of the tumor and remission or sustained improvement of MG. This is usually achievable with trans-sternal maximal thymectomy and chronic immunosuppressant medication. In this article, we consider aspects of the historical background, pathogenesis, diagnosis, and treatment of thymomatous MG. There was no mention of thymic abnormalities in the classic descriptions of myasthenia patients by Wilks, [1] Erb, [2] Goldflam, [3] and Jolly, [4] or among the autopsies reported by Campbell and Bramwell at the turn of the century [5] until 1901 when Laquer and Weigert [6,7] described a patient with myasthenia and a thymic tumor. Later, Bell, [8] Blalock, [9,10] and others found that the thymus gland in myasthenia was enlarged or the site of a tumor in the majority of patients at surgery or autopsy. Thymectomy, with the intention to resect the gland totally became standard treatment. [11-15] The estimated overall frequeny of thymoma in MG varies from 15 to 30%. [16-22] It is more common with increasing age, with an estimated frequency of 3% for age 20 years or younger, 12% for ages 21 to 45, and 35% for age 46 years and older. [23] Although detection of thymoma most often follows the clinical diagnosis of MG, …

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ccc完成签到 ,获得积分10
刚刚
刚刚
刚刚
刚刚
微雨完成签到,获得积分10
1秒前
六五完成签到 ,获得积分10
2秒前
aple完成签到,获得积分10
2秒前
orixero的应助被胡杨树2006采纳,获得10
2秒前
4秒前
4秒前
胡萝卜卜发布了新的文献求助10
5秒前
胡萝卜卜发布了新的文献求助10
5秒前
胡萝卜卜发布了新的文献求助10
5秒前
斯文败类的应助被Aleah_采纳,获得10
5秒前
5秒前
Shawna发布了新的文献求助10
6秒前
小坚果发布了新的文献求助10
6秒前
下小雨发布了新的文献求助10
6秒前
6秒前
aple发布了新的文献求助10
6秒前
6秒前
搜集达人的应助被Felix采纳,获得10
6秒前
Orange的应助被敏静采纳,获得10
6秒前
7秒前
烟花的应助被王乐乐采纳,获得10
7秒前
light完成签到 ,获得积分10
7秒前
8秒前
8秒前
8秒前
秋风的应助被诗谙采纳,获得10
9秒前
胡萝卜卜发布了新的文献求助10
9秒前
微笑老九发布了新的文献求助10
9秒前
10秒前
10秒前
爱听歌的青筠完成签到,获得积分10
11秒前
lijiansong发布了新的文献求助10
11秒前
胡萝卜卜发布了新的文献求助10
11秒前
觉多汤包发布了新的文献求助10
11秒前
胡萝卜卜发布了新的文献求助10
12秒前
小松完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193605
求助须知:如何正确求助?哪些是违规求助? 9579751
关于积分的说明 21867369
捐赠科研通 7793242
什么是DOI,文献DOI怎么找? 3437325
关于科研通互助平台的介绍 2560761
邀请新用户注册赠送积分活动 2484193